0001493152-23-002919.txt : 20230130
0001493152-23-002919.hdr.sgml : 20230130
20230130160543
ACCESSION NUMBER: 0001493152-23-002919
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230126
FILED AS OF DATE: 20230130
DATE AS OF CHANGE: 20230130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cabell Christopher
CENTRAL INDEX KEY: 0001814928
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36199
FILM NUMBER: 23567758
MAIL ADDRESS:
STREET 1: C/O ARENA PHARMACEUTICALS, INC.
STREET 2: 6154 NANCY RIDGE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pulmatrix, Inc.
CENTRAL INDEX KEY: 0001574235
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461821392
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 99 HAYDEN AVENUE
STREET 2: SUITE 390
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: (781) 357-2333
MAIL ADDRESS:
STREET 1: 99 HAYDEN AVENUE
STREET 2: SUITE 390
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: Ruthigen, Inc.
DATE OF NAME CHANGE: 20130411
4
1
ownership.xml
X0306
4
2023-01-26
0
0001574235
Pulmatrix, Inc.
PULM
0001814928
Cabell Christopher
C/O PULMATRIX, INC., 99 HAYDEN AVE
LEXINGTON
MA
02421
1
0
0
0
Stock Option (Right to Buy)
3.99
2023-01-26
4
A
0
1700
0
A
2033-01-26
Common Stock
1700
1700
D
The shares underlying this stock option will vest and become exercisable in forty-eight (48) equal monthly installments with the first tranche vesting on January 26, 2023, provided that the reporting person is providing services to the Issuer on the applicable vesting date and subject to the terms and conditions of the Pulmatrix, Inc. Amended and Restated 2013 Employee, Director and Consultant Equity Incentive Plan.
/s/ Christopher Cabell
2023-01-30